BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15945298)

  • 1. [Aldosterone blockade in essential hypertension].
    Venco A; Grandi AM
    Ital Heart J; 2005 May; 6 Suppl 1():34S-42S. PubMed ID: 15945298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive therapy: role of aldosterone antagonists.
    Grandi AM
    Curr Pharm Des; 2005; 11(17):2235-42. PubMed ID: 16026292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of disease: The role of aldosterone in kidney damage and clinical benefits of its blockade.
    Del Vecchio L; Procaccio M; Viganò S; Cusi D
    Nat Clin Pract Nephrol; 2007 Jan; 3(1):42-9. PubMed ID: 17183261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the renin-angiotensin-aldosterone system in vascular remodeling and inflammation: a clinical review.
    Duprez DA
    J Hypertens; 2006 Jun; 24(6):983-91. PubMed ID: 16685192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Aldosterone as an endogenous cardiovascular toxin and the options for its therapeutic management].
    Horký K
    Vnitr Lek; 2011 Dec; 57(12):1012-6. PubMed ID: 22277034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of aldosterone in left ventricular hypertrophy in hypertension.
    Matsumura K; Fujii K; Oniki H; Oka M; Iida M
    Am J Hypertens; 2006 Jan; 19(1):13-8. PubMed ID: 16461184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aldosterone and cardiovascular disease.
    Gaddam KK; Pimenta E; Husain S; Calhoun DA
    Curr Probl Cardiol; 2009 Feb; 34(2):51-84. PubMed ID: 19135616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardioprotection by aldosterone receptor antagonism in heart failure. Part I. The role of aldosterone in heart failure.
    Dieterich HA; Wendt C; Saborowski F
    Fiziol Cheloveka; 2005; 31(6):97-105. PubMed ID: 16366159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Myocardial fibrosis--the theoretical bases, clinical aspects and therapeutic implications].
    Perdigão C
    Rev Port Cardiol; 1993; 12(7-8):675-85, 603. PubMed ID: 8352988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Aldosterone and kidney damage: clinical implications].
    Del Vecchio L; Sitia S
    G Ital Nefrol; 2009; 26(3):347-54. PubMed ID: 19554532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldosterone antagonists: effective add-on therapy for the treatment of resistant hypertension.
    Gaddam KK; Pratt-Ubunama MN; Calhoun DA
    Expert Rev Cardiovasc Ther; 2006 May; 4(3):353-9. PubMed ID: 16716096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertension in women: the role of progesterone and aldosterone.
    Boschitsch E; Mayerhofer S; Magometschnigg D
    Climacteric; 2010 Aug; 13(4):307-13. PubMed ID: 20443718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galectin-3 blockade inhibits cardiac inflammation and fibrosis in experimental hyperaldosteronism and hypertension.
    Martínez-Martínez E; Calvier L; Fernández-Celis A; Rousseau E; Jurado-López R; Rossoni LV; Jaisser F; Zannad F; Rossignol P; Cachofeiro V; López-Andrés N
    Hypertension; 2015 Oct; 66(4):767-75. PubMed ID: 26238446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mineralocorticoid receptor activation in obesity hypertension.
    Nagase M; Fujita T
    Hypertens Res; 2009 Aug; 32(8):649-57. PubMed ID: 19521418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of target organ damage caused by hypertension: therapeutic potential.
    Cohuet G; Struijker-Boudier H
    Pharmacol Ther; 2006 Jul; 111(1):81-98. PubMed ID: 16288809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular effects of aldosterone and post-acute myocardial infarction pathophysiology.
    Cohn JN; Colucci W
    Am J Cardiol; 2006 May; 97(10A):4F-12F. PubMed ID: 16698330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Endocrinology of aldosterone].
    Ronconi V; Giacchetti G; Boscaro M
    Ital Heart J; 2005 May; 6 Suppl 1():5S-15S. PubMed ID: 15945295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aldosterone as an independent factor in cerebrovascular damage.
    Mulatero P; Caserta M; Bertello C; Schiavone D; Verhovez A; Giraudo G; Morello F; Veglio F
    Clin Exp Hypertens; 2008 Nov; 30(8):785-97. PubMed ID: 19021028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular outcomes in patients with primary aldosteronism after treatment.
    Catena C; Colussi G; Nadalini E; Chiuch A; Baroselli S; Lapenna R; Sechi LA
    Arch Intern Med; 2008 Jan; 168(1):80-5. PubMed ID: 18195199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of aldosterone in the development of postinfarction fibrosis].
    Cittadini A; Serpico R; Monti MG; Saccà L
    Ital Heart J; 2005 May; 6 Suppl 1():43S-50S. PubMed ID: 15945299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.